Helix Acquisition Corp. receives $150,000 working capital loan from affiliate Cormorant Asset Management

MoonLake Immunotherapeutics

Cormorant Asset Management LP, an affiliate of Helix officers, loaned $150,000 for working capital.
Loan is non-interest bearing, non-convertible, payable upon consummation of a business combination.
If no business combination occurs, the loan is forgiven except for funds available outside trust account.
Helix is pursuing a business combination with MoonLake Immunotherapeutics AG as previously disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.